Retrospective analysis ofin vivorecovery and clearance during continuous infusion of recombinant factor VIII products: a single-institution study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Retrospective analysis ofin vivorecovery and clearance during continuous infusion of recombinant factor VIII products: a single-institution study

Published:2016-10-05 Issue:2 Volume:23 Page:215-221
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Suzuki N.¹,Hirakawa A.²,Kishimoto M.³,Kanematsu T.⁴,Ogawa M.⁴,Kiyoi H.⁴,Matsushita T.¹

Affiliation:

1. Department of Transfusion Medicine; Nagoya University Graduate School of Medicine; Nagoya Japan

2. Biostatistics Section; Center for Advanced Medicine and Clinical Research; Nagoya University Graduate School of Medicine; Nagoya Japan

3. Department of Clinical Laboratory Medicine; Nagoya University Graduate School of Medicine; Nagoya Japan

4. Department of Hematology and Oncology; Nagoya University Graduate School of Medicine; Nagoya Japan

Funder

Bristol-Myers Squibb

Chugai Pharmaceutical Co. Ltd.

Kyowa Hakko Kirin

Dainippon Sumitomo Pharma

Zenyaku Kogyo

Fujifilm Corporation

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13082/fullpdf

Reference24 articles.

1. Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery;Batorova;Br J Haematol,2000

2. Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patients;Negrier;Thromb Haemost,2008

3. Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia;Martinowitz;Haemophilia,2009

4. Comparison of continuous and intermittent Factor VIII concentrate therapy in hemophilia A;Hathaway;Am J Hematol,1984

5. The use of continuous infusion of factor concentrates in the treatment of hemophilia;Bona;Am J Hematol,1989

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of FVIII pharmacokinetic profiles in Korean hemophilia A patients assessed with myPKFiT: a retrospective chart review;Blood Research;2024-08-28

2. A case of acquired hemophilia A after pancreaticoduodenectomy for distal cholangiocarcinoma;Biomedical Reports;2023-08-01

3. Terminal half‐life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database;Journal of Thrombosis and Haemostasis;2021-06-18

4. Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery;Haemophilia;2021-03-27

5. Monitoring coagulation factors during surgery. A systematic review;FARM HOSP;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3